Trending...
- Where Were the Women? Reframing the Greek Revolution Through Contemporary Art
- Michigan Homeowners Urged to Act on Rising Basement Waterproofing Needs Amid Severe Flood
- ENTOUCH Named Finalist for 2026 North American Inspiring Workplaces Awards
SEMINOLE, Fla. & KARLSRUHE, Germany - WisconsinEagle -- MIRAmedtech UG and Bio-Infusions USA announced today that they a have entered into an agreement, effective immediately, to provide a complete line of comprehensive aesthetic medical devices and topical treatments to cosmetic dermatologists, plastic surgeons, and aesthetic practitioners for the benefit of their patients throughout the United States.
The Companies have collaborated together in recent years to launch Bio-Infusion's Cleopatra™ branded Fractional Bio-Infusion System™, based on MIRAmedtech device technology and focused on international markets throughout Europe, the Pacific Rim and South America. This announcement comes as a result of their early success in those markets and the mutual desire to bring something truly innovative to the US market.
"There is an exciting opportunity to fill the demand for healthier and younger looking skin with a truly non-invasive treatment that takes advantage of the most current innovations in device technology and that also uses the most compelling new advances in topical bio-nutrient actives," said Serge Castro, Founder and Managing Director of MIRAmedtech UG. "That is what we are creating by combining MIRAmedtech device technologies and the encapsulated bio-active solution technologies that Bio-Infusions has created."
More on Wisconsin Eagle
All MIRApeel™ and Cleopatra™ branded devices are made in Germany by MIRAmedtech, the inventor of the phased non-invasive approach that combines transbrasion, fractional bio-infusion and LED light therapies with customized bio-nutrient topical delivery for an optimal skin-health response. The result is a dramatic improvement in skin tone and texture, supporting an overall improvement in skin health, without surgery.
"The strength of this treatment model is that it delights the patient with visible and continued improvements in the quality and appearance of their skin, at a lower cost per treatment relative to other treatment options currently available," said Paul Guilbaud, President of Bio-Infusions USA. "This combination technology is a superior compliment to their other core offerings, such as injectable fillers, IPL, or other energy-based technologies that work below the surface of the skin. This provides a superior ROI for the physician."
The Cleopatra™ and MIRApeel™ technologies are currently available throughout the USA direct from Bio-Infusions USA, Inc. and their authorized sales and distribution partners. For more information, go to www.CleopatraSkinHealth.com, write sales@bio-infusions.com or call 1-833-923-2889 ext. 2.
More on Wisconsin Eagle
ABOUT BIO-INFUSIONS USA, Inc. — Bio-Infusion develops, markets and sells highly effective non-invasive skin rejuvenation therapies for patients suffering from dermatologic conditions or desiring aesthetic improvement. The Company's leading products include the Cleopatra™ Fractional Bio-Infusion System™, a breakthrough device combining MIRAmedtech device technology with Bio-infusions® suite of potent active bio-nutrients targeting skin clarity, brightness, photo-damage and laxity for enhanced tissue delivery and improved patient outcomes. More information can be found at www.CleopatraSkinHealth.com
About MIRAmedtech U.G. — Engineered and designed to become a leader, MIRAmedtech is the inventor and manufacturer of MIRApeel™, the inventor of multi-phased non-invasive treatments that feature fractional bio-infusion, designed to make professional skin rejuvenation more effective and yet safer/more controlled. The resulting technology currently growing in popularity in over 15 countries worldwide, with a broad application in treating the range of skin tone and texture issues on the face and body. For more information, please visit www.MIRAmedtech.com
The Companies have collaborated together in recent years to launch Bio-Infusion's Cleopatra™ branded Fractional Bio-Infusion System™, based on MIRAmedtech device technology and focused on international markets throughout Europe, the Pacific Rim and South America. This announcement comes as a result of their early success in those markets and the mutual desire to bring something truly innovative to the US market.
"There is an exciting opportunity to fill the demand for healthier and younger looking skin with a truly non-invasive treatment that takes advantage of the most current innovations in device technology and that also uses the most compelling new advances in topical bio-nutrient actives," said Serge Castro, Founder and Managing Director of MIRAmedtech UG. "That is what we are creating by combining MIRAmedtech device technologies and the encapsulated bio-active solution technologies that Bio-Infusions has created."
More on Wisconsin Eagle
- Shoutout Joseph Neibich aka Nybyk
- Meet Joseph Neibich aka Joseph Nybyk of Beachwood Canyon
- LARUS Launches Business Continuity Framework for IPv4-Dependent Networks
- KeysCaribbean Offers 'Skip-the-Crowds' Savings With 15 Percent Off April Stays
- Supply & Demand Chain Executive Names Puga Sankara as Recipient of 2026 Pros to Know Award
All MIRApeel™ and Cleopatra™ branded devices are made in Germany by MIRAmedtech, the inventor of the phased non-invasive approach that combines transbrasion, fractional bio-infusion and LED light therapies with customized bio-nutrient topical delivery for an optimal skin-health response. The result is a dramatic improvement in skin tone and texture, supporting an overall improvement in skin health, without surgery.
"The strength of this treatment model is that it delights the patient with visible and continued improvements in the quality and appearance of their skin, at a lower cost per treatment relative to other treatment options currently available," said Paul Guilbaud, President of Bio-Infusions USA. "This combination technology is a superior compliment to their other core offerings, such as injectable fillers, IPL, or other energy-based technologies that work below the surface of the skin. This provides a superior ROI for the physician."
The Cleopatra™ and MIRApeel™ technologies are currently available throughout the USA direct from Bio-Infusions USA, Inc. and their authorized sales and distribution partners. For more information, go to www.CleopatraSkinHealth.com, write sales@bio-infusions.com or call 1-833-923-2889 ext. 2.
More on Wisconsin Eagle
- AI Disruption Meets Marine Scale: Off The Hook YS, Inc. (N Y S E American: OTH) Targets Breakout Growth with NextBoat Launch and Aggressive Expansion
- The Retirement Advantage, Inc. Expands Sales Force with Appointment of Brad Wehrfritz as Regio
- Targeting the Billion-Dollar U.S. Countermeasure Market With AI-Driven Biodefense Platform: Lunai Bioworks (N A S D A Q: LNAI)
- New Global Standard for Transparency Across Critical Resources and Energy Markets: SMX (Security Matters) PLC (N A S D A Q: SMX)
- Forced Psychiatric Hospitalization Fails Vulnerable People: CCHR Urges Repeal Amid Rising U.S. Policies
ABOUT BIO-INFUSIONS USA, Inc. — Bio-Infusion develops, markets and sells highly effective non-invasive skin rejuvenation therapies for patients suffering from dermatologic conditions or desiring aesthetic improvement. The Company's leading products include the Cleopatra™ Fractional Bio-Infusion System™, a breakthrough device combining MIRAmedtech device technology with Bio-infusions® suite of potent active bio-nutrients targeting skin clarity, brightness, photo-damage and laxity for enhanced tissue delivery and improved patient outcomes. More information can be found at www.CleopatraSkinHealth.com
About MIRAmedtech U.G. — Engineered and designed to become a leader, MIRAmedtech is the inventor and manufacturer of MIRApeel™, the inventor of multi-phased non-invasive treatments that feature fractional bio-infusion, designed to make professional skin rejuvenation more effective and yet safer/more controlled. The resulting technology currently growing in popularity in over 15 countries worldwide, with a broad application in treating the range of skin tone and texture issues on the face and body. For more information, please visit www.MIRAmedtech.com
Source: Bio-Infusions USA
0 Comments
Latest on Wisconsin Eagle
- Where Were the Women? Reframing the Greek Revolution Through Contemporary Art
- JGCMGS Details Architecture to Safeguard Assets From Unauthorized Phishing Scams
- 21 Days: The Malta Deadline That Could Redraw the Finnish Online Casino Map
- JEGS Launches Modern, Secure Payments Powered by PhaseZero.ai
- U.S. Government Contracts in Excess of 38 Million Secured Through Partner, Establishing Multi-Year Defense Revenue Platform Through 2032: $BLIS
- New Report Reveals Surprising Trends in Ohio Airport Accidents
- Why Your Berberine Failed: RevGenetics Unveils the Absorption Gap Solution
- WCC Kitchens and Cabinets Featured on Selling Houses Australia
- Cat Hunt Simulator : Burrow & Pounce Lands on the App Store
- Shincheonji Marks 42nd Anniversary: From a Basement to a Denomination Growing by Tens of Thousands Annually
- Jackets for Jobs Hosts Smart & Sexy® Day Detroit for Women's History Month
- Benchmark International Faciltd. the Trans BT Telmark Sales Solutions and Market Performance Group
- Hope Community Capital Launches Mission‑Driven Webinar Series For Community Facility Projects
- Autism Advocate: Why Congress Must Investigate Wisconsin's DPI
- Tint Academy Training in Dallas Texas: Learn Window Tint & PPF Installation
- $IBG accelerates toward transformative merger with BlockFuel as $6 million raise fuels dual-industry growth strategy: N A S D A Q: IBG
- High-Growth Power Infrastructure Play Targets AI Boom: 1606 Corp. Executes Aggressive Texas Expansion Strategy: 1606 Corp. (Stock Symbol: CBDW) $CBDW
- Accelerating the Transformation into a U.S. Nuclear Fuel Cycle Leader: Frontier Nuclear and Minerals Inc. (N A S D A Q: FNUC)
- Ozz Metals Ltd Secures 1-Tonne Gold Offtake Agreement
- Jet Set: The Ultimate Coachella Afterparty